OPERATION WARP SPEED AWARDS NOVAVAX $1.6 BILLION FOR COVID VACCINE | WHAT REALLY HAPPENED

OPERATION WARP SPEED AWARDS NOVAVAX $1.6 BILLION FOR COVID VACCINE

With US equity futures under pressure on Tuesday morning – it’s not surprising whatsoever that hopium-inspiring vaccine headlines are hitting the tape. Novavax was awarded $1.6 Billion in funding via Operation Warp Speed to support “large-scale manufacturing of NVX-COV2373.”

NOVAVAX ANNOUNCES $1.6 BILLION FUNDING FROM OPERATION WARP SPEED
Gaithersburg, Maryland-based Novavax said in a statement that initial production of 100 million doses would start in late 2020. The aim is to have millions of doses ready by January 2021.

NOVAVAX – OWS AWARD FUNDS LARGE-SCALE MANUFACTURING OF NVX-COV2373, INCLUDING PRODUCTION OF 100 MILLION DOSES STARTING IN LATE 2020

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA